Stock analysts at StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a report issued on Tuesday. The firm set a “sell” rating on the stock.
Ampio Pharmaceuticals Price Performance
NYSE AMPE opened at $0.00 on Tuesday. Ampio Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $1.05. The stock has a market capitalization of $681.00, a price-to-earnings ratio of 0.00 and a beta of 3.77.
Ampio Pharmaceuticals Company Profile
Featured Articles
- Five stocks we like better than Ampio Pharmaceuticals
- What is the FTSE 100 index?
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Are Tariffs Threatening Disney’s Comeback Story?
- Where Do I Find 52-Week Highs and Lows?
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
